Further, there are high resistin levels in cardiomyocytes derived from type 2 diabetic hearts, with resistin overexpression altering cardiac contractility and promoting cardiac hypertrophy potentially through the IRS1/MAPK pathway (98). The gene discussed is IRS1; the disease is cardiac hypertrophy.